HALDOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Haldol, and what generic alternatives are available?
Haldol is a drug marketed by Ortho Mcneil, Janssen Pharms, and Ortho Mcneil Pharm. and is included in five NDAs.
The generic ingredient in HALDOL is haloperidol. There are twenty drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the haloperidol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Haldol
A generic version of HALDOL was approved as haloperidol by MYLAN on June 10th, 1986.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HALDOL?
- What are the global sales for HALDOL?
- What is Average Wholesale Price for HALDOL?
Summary for HALDOL
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 5 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 139 |
Clinical Trials: | 46 |
Patent Applications: | 4,586 |
Drug Prices: | Drug price information for HALDOL |
What excipients (inactive ingredients) are in HALDOL? | HALDOL excipients list |
DailyMed Link: | HALDOL at DailyMed |
Recent Clinical Trials for HALDOL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Western Michigan University School of Medicine | Phase 4 |
Zuyderland Medisch Centrum | Phase 4 |
National Institute of Nursing Research (NINR) | Phase 2/Phase 3 |
Pharmacology for HALDOL
Drug Class | Typical Antipsychotic |
US Patents and Regulatory Information for HALDOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ortho Mcneil | HALDOL | haloperidol lactate | CONCENTRATE;ORAL | 015922-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Ortho Mcneil | HALDOL | haloperidol | TABLET;ORAL | 015921-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Janssen Pharms | HALDOL | haloperidol decanoate | INJECTABLE;INJECTION | 018701-002 | Jan 31, 1997 | AO | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for HALDOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ortho Mcneil | HALDOL | haloperidol lactate | CONCENTRATE;ORAL | 015922-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Ortho Mcneil | HALDOL | haloperidol | TABLET;ORAL | 015921-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Ortho Mcneil | HALDOL | haloperidol | TABLET;ORAL | 015921-003 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for HALDOL
See the table below for patents covering HALDOL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
United Kingdom | 895309 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |